Trending...
- Bay Miner Goes Global with Mobile Mining App for Everyday BTC, ETH & XRP Earnings
- Jones Sports Announces Enhanced Leadership
- Case Study Uncovers Major Gap in Sliding Screen Doors
PHILADELPHIA, July 1, 2025 /PRNewswire/ -- Berger Montague, a national securities litigation law firm, is investigating potential securities fraud claims against Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). The firm is examining whether Hims & Hers, during the Class Period from April 29, 2025 through June 22, 2025 (the "Class Period"), violated federal securities laws by making false or misleading statements to investors.
Details of the Securities Fraud Investigation
On June 23, 2025, shares of Hims & Hers dropped more than 34% after Novo Nordisk revealed it terminated its partnership due to the Company's unauthorized marketing and sale of compounded semaglutide drugs. A complaint has been filed alleging material misstatements and omissions in violation of federal securities laws.
Deadline to Act
Investors have until August 25, 2025 to seek appointment as lead plaintiff in the class action lawsuit. Lead plaintiffs help direct the case and advocate on behalf of other harmed investors.
More on The PennZone
If you are a Hims & Hers investor and would like to learn more about this action, CLICK HERE or please contact Berger Montague: Andrew Abramowitz at [email protected] or (215) 875-3015, or Caitlin Adorni at [email protected] or (267)764-4865.
About Berger Montague
Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco and Chicago, has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.
For more information or to discuss your rights, please contact:
Andrew Abramowitz, Senior Counsel
Berger Montague
(215) 875-3015
[email protected]
Caitlin Adorni
Berger Montague
(267) 764-4865
[email protected]
SOURCE Berger Montague
Details of the Securities Fraud Investigation
On June 23, 2025, shares of Hims & Hers dropped more than 34% after Novo Nordisk revealed it terminated its partnership due to the Company's unauthorized marketing and sale of compounded semaglutide drugs. A complaint has been filed alleging material misstatements and omissions in violation of federal securities laws.
Deadline to Act
Investors have until August 25, 2025 to seek appointment as lead plaintiff in the class action lawsuit. Lead plaintiffs help direct the case and advocate on behalf of other harmed investors.
More on The PennZone
- Grayslake Police & Fire Face Off Against "Beat Bob" in Charity Volleyball Showdown – Sept 13th, 2025
- Toyoholic.com Search Engine Finds Rare Toy Deals & Pressed Steel Classics
- TEAMSTERS CALL ON PENNSYLVANIA STATE SENATE TO SOLVE TRANSIT FUNDING CRISIS
- NASDAQ: SPPI INVESTOR ALERT: Berger Montague Advises Spectrum Pharmaceuticals (NASDAQ: SPPI) Investors of September 24, 2025 Deadline
- A New Chapter in Leadership: Announcing Four New Partners at Percy Law Group, PC
If you are a Hims & Hers investor and would like to learn more about this action, CLICK HERE or please contact Berger Montague: Andrew Abramowitz at [email protected] or (215) 875-3015, or Caitlin Adorni at [email protected] or (267)764-4865.
About Berger Montague
Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco and Chicago, has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.
For more information or to discuss your rights, please contact:
Andrew Abramowitz, Senior Counsel
Berger Montague
(215) 875-3015
[email protected]
Caitlin Adorni
Berger Montague
(267) 764-4865
[email protected]
SOURCE Berger Montague
Filed Under: Business
0 Comments
Latest on The PennZone
- BEC Technologies Achieves ITxPT Certification for M600-M12-FA 5G Industrial Router
- Hyperion Bank Included in Inc. 5000 for Second Year
- SentioMind Foundation Launches Revolutionary AI-Powered Autonomous Workforce Platform
- International Group Art Exhibition KALEIDOSCOPE: SMALL WORLDS at Art Mozaik Fine Art Gallery, Santa Fe
- Attorney Ron Makarem of Sexual Harassment Law Firm CA Leads Fight Against Workplace Harassment in California
- Oracle Striker Foundation Unveils Revolutionary Football Talent Investment Platform
- Sanadatum(SDTM) Foundation Launches Revolutionary Health Data Economy Platform
- DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of The Manpower of Lansing, MI Inc. Customers Whose Data May Have Been Compromised
- Bookmakers Review: Shohei Ohtani Leads 2025 TIME Athlete of the Year Betting Market
- OddsTrader Releases 2025-26 NFL Passing Leader Odds — Can Anyone Top Joe Burrow?
- Exeter Smiles in Reading PA Uses DIBS AI to Transform Braces Treatment
- Post-Hoc FUEL Trial Analysis Shows Udenafil Significantly Improves Exercise Capacity in Fontan Patients with Reduced Baseline Function
- New Arts Hub in NEPA Launches Harvest Groove Festival
- Genpak Increases Foodservice Packaging Efficiency for Emerging Restaurants
- Pew Awards 22 Researchers Biomedical Science Grants
- Where You Play Matters: MrBet Decodes Europe's Complex Gambling Tax Rules in New Report
- Travel Easy, Travel Smart: Jokari Introduces the Cart Cruiser Pet Carrier Travel Bag
- $1 Million Equity Dividend Ignites Investor Frenzy as AI & Cybersecurity Titans IQSTEL (N A S D A Q: IQST) & Cycurion (N A S D A Q: CYCU) Join Forces
- From Paris to Rome to Venice — The World's No.1 Superstar™ Claims Another City with Bad Boy's Wild Ride
- Digital Dawn Launches Revolutionary Bitcoin Copy Trading Platform With 30-40% Monthly Returns